# Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

> **NCT03738761** · PHASE4 · COMPLETED · sponsor: **KRKA** · enrollment: 471 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Amlessa®
- **DRUG:** Co-Amlessa®

## Key facts

- **NCT ID:** NCT03738761
- **Lead sponsor:** KRKA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-13
- **Primary completion:** 2019-09-27
- **Final completion:** 2019-09-27
- **Target enrollment:** 471 (ACTUAL)
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738761, "Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03738761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*